Gas tamponade is more effective for RRD

Article

Using a gas tamponade, compared to an air tamponade, is more effective when treating rhegmatogenous retinal detachment (RRD).

Using a gas tamponade, compared to an air tamponade, is more effective when treating rhegmatogenous retinal detachment (RRD).

A team led by Dr H Stevie Tan, Academic Medical Center, University of Amsterdam, The Netherlands, examined the records of 524 cases of 523 patients that experienced primary vitrectomy for RRD with air or sulphur hexafluoride with a follow-up of at least three months. Cases with inferior retinal breaks were excluded from the study.

Of the patients included in the studied, 318 were treated with gas and 128 were treated with air. Eyes treated with air and gas had 81% and 86.9% chance of primary success, respectively.

A confounding factor was the involvement of lower retinal quadrants in the retinal detachment (RD). After this confounder was corrected the comparison between air and gas tamponade was statistically significant with regards to success rate.

Overall, gas tamponades are superior to air tamponades in RD cases with involvement of the lower quadrants. Air tamponades should only be used in RDs that are restricted to the superior quadrants.

The abstract can be found in the British Journal of Ophthalmology.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Related Content
© 2025 MJH Life Sciences

All rights reserved.